IL34 and hepatocellular carcinoma: IL34+ CAFs enhance the proliferation activity of CAFs, promote differentiation of Tregs, and suppress CD8+ T cell cytotoxicity, leading to immune escape and promoting the growth and metastasis of HCC (Fig. 8).